Kingworld Medicines Group Limited (HKG:1110)

Hong Kong · Delayed Price · Currency is HKD

0.3950

+0.0450 (12.86%)

Jul 10, 2026, 4:08 PM HKT

-26.85% (1Y)

Market Cap	234.02M -31.6%
Revenue (ttm)	1.02B -13.5%
Net Income	12.55M -72.9%
EPS	0.02 -73.3%
Shares Out	592.46M
PE Ratio	18.44
Forward PE	n/a
Dividend	0.03 (8.03%)
Ex-Dividend Date	Jun 5, 2025

Volume	2,648,000
Open	0.3600
Previous Close	0.3500
Day's Range	0.3500 - 0.4200
52-Week Range	0.3300 - 0.7800
Beta	0.84
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Kingworld Medicines Group

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, and Kingworld Imada Red Flower Oil brands. It also manufactur... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 1996

Employees 732

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1110

Full Company Profile

Financial Performance

In 2025, Kingworld Medicines Group's revenue was 917.34 million, a decrease of -13.55% compared to the previous year's 1.06 billion. Earnings were 11.28 million, a decrease of -72.85%.

Financial numbers in CNY Financial Statements